Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 402 across all filing types
Latest filing 2025-02-05 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Stock Exchange under Chapter 19B listing rules, detailing movements in authorised/registered share capital, issued shares, share options, RSUs, and other capital arrangements. It is not an AGM presentation, earnings release, or full financial report, nor is it a one-off transaction or insider dealing. It is a routine regulatory filing falling under miscellaneous regulatory announcements. Therefore, it is best classified as a Regulatory Filing (RNS).
2025-02-05 English
INTERIM KEY FINDINGS OF INDEPENDENT INVESTIGATION
Regulatory Filings Classification · 1% confidence The document is an announcement under Hong Kong Listing Rules detailing the interim key findings of an independent forensic investigation commissioned by the Board. It is not a financial statement (10-K, IR), earnings release (ER), management change (MANG), or dividend notice (DIV). It primarily summarizes an internal investigation and is published as a regulatory announcement to shareholders and the Stock Exchange. It does not constitute a full audit report, call transcript, proxy statement, or other specific categories. It therefore falls into the residual category for general regulatory announcements (RNS).
2025-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings Classification · 1% confidence The document is a mandatory HKEX Form FF301 “Monthly Return for Equity Issuer” under Chapter 19B, detailing movements in authorized/registered share capital, issued shares, share options, RSU schemes, and confirmations. It is a routine regulatory submission rather than an earnings release, annual report, or investor presentation. It does not announce a report publication but constitutes the report itself. Therefore, it falls under the fallback category "Regulatory Filings" (RNS).
2025-01-07 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 1% confidence The document is a formal listing of the company’s board composition and committee structures, detailing the roles and governance framework. It is not announcing specific board changes (appointments or resignations) but rather lays out the internal governance structure. This aligns with Governance Information (CGR).
2025-01-01 English
NON-COMPLIANCE WITH THE LISTING RULES
Board/Management Information Classification · 1% confidence The document is a public announcement by Sirnaomics Ltd. regarding the resignation of independent non-executive directors, resulting in non-compliance with Hong Kong Listing Rules and board composition requirements. It outlines board-level changes and planned actions to fill vacancies. This falls squarely under announcements of changes in the company’s board of directors (Board/Management Information).
2025-01-01 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 30, 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an announcement of the poll results of an Extraordinary General Meeting (EGM), detailing the votes cast for each resolution, percentages, and whether resolutions were passed. It is a declaration of voting results rather than the report itself or an investor presentation. Therefore, it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-12-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.